First-Line Anlotinib in Chemotherapy-Ineligible Patients With Soft Tissue Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-Line Anlotinib Treatment for Soft Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-label, Single-arm, Phase 2 Clinical Trial
Clin. Cancer Res 2024 Mar 14;[EPub Ahead of Print], T Li, Y Dong, Y Wei, S Wang, Y Liu, J Chen, W Xiong, N Lin, X Huang, M Liu, X Yan, Z Ye, B LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.